Nepsis Inc. Fulgent Genetics, Inc. Transaction History

Nepsis Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$47.98 - $62.75 $5.39 Million - $7.05 Million	-112,306 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$49.85 - $96.11 $918,735 - $1.77 Million	18,430 Added 19.63%	112,306 $7.01 Million
Q4 2021 Jan 14, 2022	SELL	$77.3 - $105.0 $7.71 Million - $10.5 Million	-99,707 Reduced 51.51%	93,876 $9.44 Million
Q3 2021 Oct 13, 2021	SELL	$74.87 - $110.87 $821,548 - $1.22 Million	-10,973 Reduced 5.36%	193,583 $17.4 Million
Q2 2021 Jul 15, 2021	BUY	$66.8 - $100.45 $926,582 - $1.39 Million	13,871 Added 7.27%	204,556 $18.9 Million
Q1 2021 Apr 20, 2021	SELL	$59.3 - $183.85 $3.6 Million - $11.2 Million	-60,668 Reduced 24.14%	190,685 $18.4 Million
Q4 2020 Jan 22, 2021	BUY	$31.01 - $52.1 $7.79 Million - $13.1 Million	251,353 New	251,353 $13.1 Million

195

15.3M

1.07M

27.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $657M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Nepsis Inc., based on Form 13F filings with the SEC.

Stay updated on Nepsis Inc. with notifications on news.